Replies to post #282372 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

so where was Leo on SARS?

The poster who reminded us about the Leo superbug PR nailed it- opportunistic insulting publicity.

Let's call it duplicity

[spoodio]

Yes, that makes total sense. I could not find any literature supporting antiviral activity , but maybe there is some evidence not in the public of anti viral activity....but anti-inflammatory, makes total sense! Also secondary infections (pneumonia, etc.) are a problem, which could be treated by B.

[BooDog]

That's exactly how I understand Brilacidin's benefit to help control COVID-19 to give patients more of a chance to battle the virus with Brilacidin's moa as an anti inflammatory. data to date just may peak some interest.

Just need the right doctors to take note.

Message in reply to:

It appears that much of caronavirus damage is due to cytokinetic storms among other severe immuno-responses to infection. COVID-19 damage, like SARS and MERS, is mostly centered on swelling of the alveoli which blocks oxygen and carbon dioxide transmission. If Brilacidin should work as a treatment against infections, it’s likely to be the anti-inflammatory properties rather than antiviral. Since an effective vaccine is likely 2 or more years away, simply suppressing immune response might limit damage.

Also, there are no grants available for anti influenzas that aren’t already glommed onto by Big Pharma and very well-connected startups.